What Researchers Did
Researchers retrospectively analyzed 52 cases of advanced head and neck cancer treated with 434-MHz radiowave hyperthermia combined with cobalt radiotherapy and/or radioactive gold grain implant.
What They Found
They found that 94% of cases achieved complete resolution of primary and secondary lesions, with a three-year survival rate of 54%. This compared favorably to 62.5% resolution and 29% survival with hyperbaric oxygen and cobalt, and 36.5% resolution and 19% survival with conventional supervoltage therapy.
What This Means for Canadian Patients
Canadian patients with advanced head and neck cancer could potentially see improved outcomes with combined microwave therapy. This approach may offer higher rates of tumor resolution and better long-term survival compared to existing conventional treatments.
Canadian Relevance
There is no direct Canadian connection mentioned in this study.
Study Limitations
The retrospective nature of this study limits the generalizability and strength of its conclusions due to potential biases.